AIDS Drug Patent

Nature - United Kingdom
doi 10.1038/331553d0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Rationalizing the Drug Patent System

Health Affairs
MedicineHealth Policy
2001English

AIDS and Intravenous Drug Use.

BMJ
1987English

AIDS Drug: Experiencing Local Delays

Science
MultidisciplinaryPhilosophy of ScienceHistory
1995English

HIV/AIDS Treatment Is Easier but Drug-Drug Interactions?

Mediterranean Journal of Infection, Microbes and Antimicrobials
Infectious DiseasesImmunologyMicrobiologyMicrobiology
2019English

“To Patent or Not to Patent? The Case of Novartis’ Cancer Drug Glivec in India”

Globalization and Health
Health PolicyPublic HealthOccupational HealthEnvironmental
2014English

Unsettling Drug Patent Settlements: A Framework for Presumptive Illegality

2009English

Drug Repurposing Patent Documents vs Peer Review: Patent Information Comes More Than 600 Days Earlier on Average

Future Drug Discovery
2020English

Injection Drug Use, Mortality, and the AIDS Epidemic.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1991English

Assessment of Generic Drug Policy Implementation by Measuring Persistence With Antihypertensive Drug Therapies After Patent Expiry

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy